Equities

Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

Actions
  • Price (HKD)1.80
  • Today's Change-0.02 / -1.10%
  • Shares traded480.00k
  • 1 Year change-52.88%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, cash reserves at Immunotech Biopharm Ltd fell by 6.29m. Cash Flow from Financing totalled 273.92m or -- of revenues. In addition the company used 163.63m for operations while cash used for investing totalled 116.60m.
Cash flow per share-0.5301
Price/Cash flow per share--
Book value per share0.1715
Tangible book value per share0.1262
More ▼

Balance sheet in CNYView more

Immunotech Biopharm Ltd has a Debt to Total Capital ratio of 61.19%, a higher figure than the previous year's 29.66%.
Current ratio0.3781
Quick ratio0.3638
Total debt/total equity1.52
Total debt/total capital0.6119
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.